Cella Therapeutics, LLC

City:

Miami, Florida

Country:

United States

Published Applications:

Last publication date:

2021-04-08

Patent Grants:

Last grant date:

2024-10-29

Top Inventors for applications by Cella Therapeutics, LLC

These are the the leading inventors for applications assigned to Cella Therapeutics, LLC:

Rhett M. Schiffman 2 Laguna Beach, CA United States
Lukas Scheibler 2 Laguna Beach, CA United States

Recent patent applications by Cella Therapeutics, LLC

Cella Therapeutics, LLC based in Miami, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-04-08 ✅ Patent 12,128,104 granted on 2024-10-29

US20210100907A1

Human necessities

Drug delivery systems comprising a neurotrophic agent, an apoptosis signaling fragment inhibitor (FAS) or FAS ligand (FASL) inhibitor, a tumor necrosis factor-alpha (TNF-alpha) or TNF receptor inhibitor, a mitochondrial peptide, an oligonucleotide, a chemokine inhibitor, or a cysteine-aspartic protease inhibitor

#2 | 2020-04-09 ✅ Patent 11,147,855 granted on 2021-10-19

US20200108117A1

Human necessities

Methods for treating glaucoma or ocular hypertension comprising delivery of prostaglandins to the vitreous humour

Also check out Cella Therapeutics, LLC's (Miami, United States) applicant profile with 3 patent applications submitted.

AssigneeID:

594636 ⎘